Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Neoplasm Metastasis 1Melanoma 1Diabetes Mellitus, Insulin-Dependent, 12 1Brain Neoplasms 1

Interventions

Ipilimumab 12tremelimumab 6durvalumab 6Nivolumab 6pembrolizumab 4Paclitaxel 2Oxaliplatin 2Carboplatin 2Capecitabine 2Blood Specimen Collection 2spartalizumab 1relatlimab 1lenvatinib 1folfirinox 1Vaccines 1Radiotherapy 1Radiofrequency Ablation 1Radiation 1Opdualag 1Monophenol Monooxygenase 1Leucovorin 1Fluorouracil 1Docetaxel 1Cryosurgery 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Diabetes Mellitus, Insulin-Dependent, 12 × Opdualag × Clear all
NCT04326257 2026-01-08

Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy

University of Pittsburgh

Phase 2 Completed
20 enrolled 13 charts
Head & Neck

Diabetes Mellitus, Insulin-Dependent, 12, Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡